Prognostic significance of urine neutrophil gelatinase-associated lipocalin in patients with septic acute kidney injury

Experimental and Therapeutic Medicine

Volumn 2, Issue 6, 2011, Pages 1133-1139

  Guo, Yong ^a   Yan, Kui Po ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Acute kidney injury; APACHE II; Prognostic significance; Urine kidney injury molecule 1; Urine neutrophil gelatinase associated lipocalin

Indexed keywords

CREATININE; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN;

ACUTE KIDNEY FAILURE; ADULT; ARTICLE; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; EVENT FREE SURVIVAL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PILOT STUDY; PREDICTOR VARIABLE; PROGNOSIS; SEPSIS; URINALYSIS;

EID: 80052755713     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2011.339     Document Type: Article

References (46)

1. Riedemann NC, Guo RF and Ward PA: The enigma of sepsis. J Clin Invest 112: 460-467, 2003.
2. Rangel-Frausto MS, Pittet D, Costigan M, et al: The natural history of the systemic inflammatory response syndrome (SIRS): a prospective study. JAMA 273: 117-123, 1995.
3. Uchino S, Kellum JA, Bellomo R, et al: Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA 294: 813-818, 2005.
4. Angus DC, Linde-Zwirble WT, Lidicker J, et al: Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 29: 1303-1310, 2001.
5. Edelstein CL and Schrier RW: Pathophysiology of ischemic acute renal failure. In: Schrier RW (ed): Diseases of the Kidney and Urinary Tract. 7th edition. Vol. 2. Lippincott Williams & Wilkins, Philadelphia, pp1041-1069, 2001.
6. Cowland JB and Borregaard N: Molecular characterization and pattern of tissue expression of the gene for neutrophil gelatinase-associated lipocalin from humans. Genomics 45: 17-23, 1997.
7. Cowland JB, Sorensen OE, Schested M, et al: Neutrophil gelatinase-associated lipocalin is up-regulated in human epithelial cells by IL-1β but not by TNF-α. J Immunol 171: 6630-6639, 2003.
8. Mishra J, Mori K, Ma Q, et al: Amelioration of ischemic acute renal injury by neutrophil gelatinase-associated lipocalin. JAm Soc Nephrol 15: 3073-3082, 2004.
9. Mishra J, Dent C, Tarabishi R, et al: Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet 365: 1231-1238, 2005.
10. Boldt J, Brenner T, Lehmann A, et al: Is kidney function altered by the duration of cardiopulmonary bypass? Ann Thorac Surg 75: 906-912, 2003.
11. Bellomo R and Ronco C: Acute renal failure-definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 8: R204-R212, 2004.
12. Levy MM, Fink MP, Marshall JC, et al: 2001 SCCM/ESICM/ACCP/ATS/SIS international sepsis definitions conference. Crit Care Med 31: 1250-1256, 2003.
13. Charlson ME, Pompei P, Ales KL, et al: A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40: 373-383, 1987.
14. Nickolas TL, O'Rourke MJ, Yang J, et al: Sensitivity and specificity of a single emergency department measurement of urinary neutrophil gelatinase-associated lipocalin for diagnosing acute kidney injury. Ann Intern Med 148: 810-819, 2008.
15. Slot C: Plasma creatinine determination: a new and specific Jaffe reaction method. Scand J Clin Lab Invest 17: 381-387, 1965.
16. Brivet F, Kleinknecht D, Loirat P, et al: The French study group on acute renal failure: acute renal failure in intensive care units-causes, outcome, and prognostic factors on hospital mortality: a prospective, multicenter study. Crit Care Med 24: 192-198, 1996.
17. Liano F, Junco E, Pascual J, et al: The spectrum of acute renal failure in the intensive care unit compared to that seen in other settings. Kidney Int 53 (Suppl 66): 16-24, 1998.
18. Neveu H, Kleinknecht D, Brivet F, et al: Prognostic factors in acute renal failure due to sepsis. Results of a prospective multicentre study. Nephrol Dial Transplant 11: 293-299, 1996.
19. Cole L, Bellomo R, Silvester W, et al: A prospective, multi-center study of the epidemiology, management, and outcome of severe acute renal failure in a 'closed' ICU system. Am J Respir Crit Care Med 162: 191-196, 2000.
20. Wan L, Bagshaw SM, Langenberg C, et al: Pathophysiology of septic acute kidney injury: what do we really know? Crit Care Med 36: S198-S203, 2008.
21. Wan L, Bellomo R, di Giantomasso D, et al: The pathogenesis of septic acute renal failure. Curr Opin Crit Care 9: 496-502, 2003.
22. Langenberg C, Wan L, Egi M, et al: Renal blood flow in experimental septic acute renal failure. Kidney Int 69: 1996-2002, 2006.
23. Brenner M, Schaer GL, Mallory DL, et al: Detection of renal blood flow abnormalities in septic and critically ill patients using a newly designed indwelling thermodilution renal vein catheter. Chest 98: 170-179, 1990.
24. Lucas CE, Rector FE, Werner M, et al: Altered renal homeostasis with acute sepsis. Clinical significance. Arch Surg 106: 444-449, 1973.
25. Rector F, Goyal S, Rosenberg IK, et al: Renal hyperemia is associated with clinical sepsis. Surg Forum 23: 51-53, 1972.
26. Bellomo R, Bagshaw S, Langenberg C, et al: A flawed paradigm in critically ill septic patients? Contrib Nephrol 156: 1-9, 2007.
27. Bagshaw SM, Langenberg C, Haase M, et al: Urinary biomarkers in septic acute kidney injury. Intensive Care Med 33: 1285-1296, 2007.
28. Bagshaw SM, Langenberg C, Wan L, et al: A systematic review of urinary findings in experimental septic acute renal failure. Crit Care Med 35: 1592-1598, 2007.
29. Schrier RW: Urinary indices and microscopy in sepsis-related acute renal failure. Am J Kidney Dis 48: 838-841, 2006.
30. Bagshaw SM, George C and Bellomo R: Early acute kidney injury and sepsis: a multicentre evaluation. Crit Care 12: R47, 2008.
31. Bagshaw SM, Uchino S, Bellomo R, et al: Septic acute kidney injury in critically ill patients: clinical characteristics and outcomes. Clin J Am Soc Nephrol 2: 431-439, 2007.
32. Bagshaw SM, Lapinsky S, Dial S, et al: Acute kidney injury in septic shock: clinical outcomes and impact of duration of hypotension prior to initiation of antimicrobial therapy. Intensive Care Med 35: 871-881, 2009.
33. Kjeldsen L, Cowland JB and Borregaard N: Human neutrophil gelatinase-associated lipocalin and homologous proteins in rat and mouse. Biochim Biophys Acta 1482: 272-283, 2000.
34. Bennett M, Dent CL, Ma Q, et al: Urine NGAL predicts severity of acute kidney injury after cardiac surgery: a prospective study. Clin J Am Soc Nephrol 3: 665-673, 2008.
35. Dent CL, Ma Q, Dastrala S, et al: Plasma neutrophil gelatinase-associated lipocalin predicts acute kidney injury, morbidity and mortality after pediatric cardiac surgery: a prospective uncontrolled cohort study. Crit Care 11: R127, 2007.
36. Haase-Fielitz A, Bellomo R, Devarajan P, et al: Novel and conventional serum biomarkers predicting acute kidney injury in adult cardiac surgery: a prospective cohort study. Crit Care Med 37: 553-560, 2009.
37. Mishra J, Mori K, Ma Q, et al: Neutrophil gelatinase-associated lipocalin: a novel early urinary biomarker for cisplatin nephrotoxicity. Am J Nephrol 24: 307-315, 2004.
38. Wagener G, Jan M, Kim M, et al: Association between increases in urinary neutrophil gelatinase-associated lipocalin and acute renal dysfunction after adult cardiac surgery. Anesthesiology 105: 485-491, 2006.
39. Bachorzewska-Gajewska H, Malyszko J, Sitniewska E, et al: Neutrophil-gelatinase-associated lipocalin and renal function after percutaneous coronary interventions. Am J Nephrol 26: 287-292, 2006.
40. Haase M, Haase-Fielitz A, Bellomo R, et al: Sodium bicarbonate to prevent increases in serum creatinine after cardiac surgery: a pilot double-blind, randomized controlled trial. Crit Care Med 37: 39-47, 2009.
41. Trachtman H, Christen E, Cnaan A, et al: Urinary neutrophil gelatinase-associated lipocalcin in D+HUS: a novel marker of renal injury. Pediatr Nephrol 21: 989-994, 2006.
42. Zappitelli M, Washburn KM, Arikan AA, et al: Urine NGAL is an early marker of acute kidney injury in critically ill children. Crit Care 11: R84, 2007.
43. Nickolas TL, Barasch J and Devarajan P: Biomarkers in acute and chronic kidney disease. Curr Opin Nephrol Hypertens 17: 127-132, 2008.
44. Bolignano D, Coppolino G, Campo S, et al: Urinary neutrophil gelatinase-associated lipocalin (NGAL) is associated with severity of renal disease in proteinuric patients. Nephrol Dial Transplant 23: 414-416, 2008.
45. Bolignano D, Coppolino G, Campo S, et al: Neutrophil gelatinase-associated lipocalin in patients with autosomal-dominant polycystic kidney disease. Am J Nephrol 27: 373-378, 2007.
46. Stevens LA, Coresh J, Greene T, et al: Assessing kidney function measured and estimated glomerular filtrationrate. N Engl J Med 354: 2473-2483, 2006.